Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network
{{output}}
Background: Chronic graft-versus-host disease (cGVHD) affects up to 54% of allogeneic hematopoietic cell transplantation (HCT) recipients and is the leading cause of late non-relapse morbidity and mortality. Despite the availabil... ...
